Literature DB >> 2732009

Cancer among New York men at risk of acquired immunodeficiency syndrome.

R J Biggar1, W Burnett, J Mikl, P Nasca.   

Abstract

In the United States, New York City has had the greatest number of subjects at risk of AIDS for the longest period of time. This population therefore serves as an indicator of changes in cancer risk which may emerge among persons at risk from AIDS. Using a proportional incidence method, we surveyed cancers occurring among single (a surrogate for homosexual) young men and married young men in Manhattan, the rest of New York City, and the remainder of New York State. The baseline period was established earlier to be 1973-76, during which time no cases of Kaposi's sarcoma were observed among single men in Manhattan. By 1985, the frequency of Kaposi's sarcoma in this group was increased 1,850-fold (compared with expected cases derived from other registries). In the same group, the increase of non-Hodgkin's lymphoma was 6.2-fold (p for trend less than 0.0001), with excesses of Burkitt's lymphoma and immunoblastic lymphoma being most noticeable. Diagnoses of Hodgkin's disease increased markedly in 1985 but not earlier. Since this pattern did not follow that of the AIDS epidemic in this area, we suggest that Hodgkin's disease is not an AIDS-associated tumor. Hepatoma was diagnosed more frequently in single young men during the 1980s but similar increases also were observed in married men and thus may be unrelated to AIDS. Thus, only Kaposi's sarcoma and non-Hodgkin's lymphoma appear to be AIDS-associated tumors, at least so far. With better treatment and longer survival, it remains possible that other tumors will emerge as part of the AIDS epidemic.

Entities:  

Mesh:

Year:  1989        PMID: 2732009     DOI: 10.1002/ijc.2910430605

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Cancer and HIV infection.

Authors:  L Hughes-Davies; M Spittle
Journal:  BMJ       Date:  1991-03-23

2.  Locus-specific de novo methylation down-regulates MHC class I in S49 lymphomas.

Authors:  R J Rubocki; B E Berrigan; S L Speaks; J L Wisecarver
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

3.  Prevalence of antibodies to HPV16-E7-protein does not differ between AIDS-patients with and without Kaposi's sarcoma.

Authors:  G Gross; H Pfister; B Wagner; N Brockmeyer
Journal:  Genitourin Med       Date:  1994-02

4.  Impact of the human immunodeficiency virus epidemic on mortality trends in young men, United States.

Authors:  J W Buehler; O J Devine; R L Berkelman; F M Chevarley
Journal:  Am J Public Health       Date:  1990-09       Impact factor: 9.308

5.  Trends of Kaposi's sarcoma at AIDS diagnosis in Europe and the United States, 1987-94.

Authors:  S Franceschi; L Dal Maso; A Lo Re; D Serraino; C La Vecchia
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 6.  Lung cancer in HIV infected patients: facts, questions and challenges.

Authors:  J Cadranel; D Garfield; A Lavolé; M Wislez; B Milleron; C Mayaud
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

Review 7.  Malignant tumours in patients with HIV infection.

Authors:  U Tirelli; S Franceschi; A Carbone
Journal:  BMJ       Date:  1994-04-30

8.  Trends in incidence of anal cancer in Denmark.

Authors:  M Frisch; M Melbye; H Møller
Journal:  BMJ       Date:  1993-02-13

9.  Assessing the relationship between marital status and cancer incidence: methodologic considerations.

Authors:  K Zhu; N S Weiss; S M Schwartz; J R Daling
Journal:  Cancer Causes Control       Date:  1994-01       Impact factor: 2.506

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.